Present findings support the concept that activation of IGF1R and AKT signaling represents a potential strategy to maintain or restore defects in alveologenesis in preterm infants at risk for the complications of BPD after birth. This evidence concerns the gene IGF1R and bronchopulmonary dysplasia.